Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO).

Clinical trial NCT01090323 · COMPLETED

Trial details

NCT number: NCT01090323
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2004-07-01
Primary completion: 2009-07-01
Enrollment: 185

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.